Alcon to acquire STAAR Surgical for about $1.5B
BTIG analyst Ryan Zimmerman called the transaction “a solid deal” for Alcon given STAAR’s struggles in the China market.
BTIG analyst Ryan Zimmerman called the transaction “a solid deal” for Alcon given STAAR’s struggles in the China market.
The survey also found high rates of alternative funding programs, controversial arrangements in which employers outsource access to pricey specialty drugs to third parties.
Albert Bourla confirmed that he called President Donald Trump after receiving a letter asking Pfizer and a clutch of other pharmaceutical companies to lower drug prices or face consequences.
Pfizer CEO in Touch With President Over Most Favored Nation Drug Pricing Read More »
A clause in Wayne DeVeydt’s new contract prevents him from participating in activities that compete with UnitedHealth. That’s standard for senior executives.
Incoming UnitedHealth CFO steps down from Centene’s board Read More »
The number of biopharma professionals let go has increased year over year for three straight months. In July, nearly 8,000 people lost their jobs, due largely to Merck cutting roughly 6,000 employees. Sarepta Therapeutics and Moderna also announced significant workforce reductions.
BMN 390 fell short of an immunogenicity threshold that BioMarin was looking for to support its further development. Employees working on the program have been redeployed within the company.
BioMarin Axes Pre-Clinical PKU Drug, Citing Underwhelming Immunogenicity Read More »
Unos científicos han creado la célula artificial más sencilla del mundo capaz de navegar químicamente, migrando hacia sustancias específicas como lo hacen las células vivas. El logro es obra de un equipo que incluye especialistas del Instituto de Bi …
Crean una célula artificial capaz de orientarse utilizando solo la química Read More »
Un nuevo biosensor nanofotónico permite detectar la bacteria Helicobacter pylori de forma precisa, directa, rápida y sin necesidad de marcadores. Esta bacteria es capaz de provocar patologías gástricas como úlceras, linfoma MALT o cáncer gástrico. Ade …
CEO Christian Mazzi said the minimally invasive surgical technique could provide better outcomes for patients than transcatheter aortic valve replacement.
First Corcym aortic valve implanted via new robotic procedure Read More »
Vertex reported healthy revenue in its second quarter earnings report, though news of VX-993’s mid-stage trial results and lack of alignment with the FDA regarding an expanded label for Journavx tempered analyst reactions, sending the stock down 13%.
Trial Failure of Vertex’s Next-Gen Pain Drug Mars Strong Q2 Earnings Read More »